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The Journal of Legal Medicine, Volume 2, Number 3, 1981

AMNIOCENTESIS AND THE APOTHEOSIS
OF HUMAN QUALITY CONTROL
Jacqueline M. Nolan-Haley, J.D., LL.M.*

INTRODUCTION
Five years ago I wrote of what I perceived to be the gradual metamorphosis of the value of life ethic in favor of a quality of life ethic.' The
former attaches value to all human life if for no other reason than it is
human. The latter ethic determines first what is human and then applies a
value to it.
What prompted my consideration of this issue was an announcement
by two Yale physicians that forty-three infants had been allowed to die at
Yale-New Haven Hospital after a joint decision by parents and physicians
that "prognosis for meaningful life was poor or hopeless."' My concern
was twofold: would such decisions be restricted to the newborn nursery;
and, who would be the ultimate arbiter of "meaningful life"?
During the past five years the quality of life ethic has continued to
displace the traditional ethic. Due to advances in genetics, particularly the
pre-natal diagnostic technique of amniocentesis, and the revival of the
eugenics movement, the concept of "meaningful life" has assumed
added dimension in utero.
The reasons offered by women who undergo amniocentesis vary
Member of the New York and Massachusetts Bars. Address reprint requests to Ms. Nolan-Haley at
331 West 71st Street, New York, New York, 10023.
Nolan-Haley, Defective Children, Their Parentsand the Death Decision, J. LEGAL MED., Jan.,
1976, at 9.
2 Duff. Moral and Ethical Dilemmas in the Special Care Nursery, 289 NEw ENG. J. MED.. 890
(1973).
'See generally T. HOWARD & J. RIFKIN, WHO SHOULD PLAY GOD? (1977). See also Sammons.
Ethical Issues in Genetic Intervention, 23 Soc. WORK 237, 240 (1978).
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from a desire to know if a child has a genetic defect, an interest in
learning the child's sex or simply the desire to have a beautiful baby.' Prenatal detection of defects followed by abortion of those deemed "defective" has reduced the number of death decisions being made in newborn
nurseries.
Under a quality of life ethic this is perceived as a "good." It spares
parents the agony of making life/death decisions of the Yale-New Haven
Hospital type and it fulfills what one physician has referred to as the
societal interest in assuring only quality products.' Under a value of life
ethic, however, this mode of behavior is unacceptable. A New Jersey
court has articulated the concern:
A child need not be perfect to have a worthwhile life ... The sanctity of the
single human life is the decisive factor in this suit in tort. Eugenic considerations are not controlling. We are not here talking about the breeding of prize
cattle.'

Under either ethic the question remains whether we are talking about
and indeed encouraging the breeding of prize cattle. This article focuses
upon the question in the context of consideration of amniocentesis and its
significance for the legal and medical community.
I. AMNIOCENTESIS
The most prevalent method of genetic screening is amniocentesis, a
pre-natal diagnostic technique which, when combined with abortion,
provides the greatest guarantee of a quality child that physicians can
accommodate in this age of consumerism.' It does not follow, however,
that normal results subsequent to performance of amniocentesis assure
that a child is without malformations.! While amniocentesis has been
*Golbus. Conte, Schneider & Epstein, Intrauterine Diagnosis of Genetic Defects: Results,
Problems, and Follow-Up of One Hundred Cases in a Prenatal Genetic Detection Center, 118 AM.
J. OBST. & GYN. 897 (1974). See also Brody, How Doctors Can Assure More Perfect Babies,
WOMAN'S DAY, Feb.. 1977. at 65.
Morrison. Implications of Prenatal Diagnosis for the Quality of and Right to, Human Life:
AND THE
Society as Standard. in ETHICAL ISSUES IN HUMAN GENETICS: GENETIC COUNSELING

UsL OF GENETIC KNOWLEDGE 201-211 (B. Hilton, ed.. 1973).

Gleitman v. Cosgrove. 49 N.J. 22, 30. 227 A.2d 689, 693 (1967), rev'd in part, Berman v. Allen,
80 N.J. 421, 404 A.2d 8 (1979).
Sammons, supra note 3, at 238. Other methods of genetic screening are ultrasonography,
radiography and fetoscopy. maternal blood and urine sampling. Goodner, Prenatal Genetic
Diagnosis: Present and Future, 19 CLIN. OsT. & GYN. 965-76 (1976).
'Editorial. Prenatal Diagnosis of Downs Syndrome, 242 J.A.M.A. 2326 (1979).

HUMAN QUALITY CONTROL

349

praised as a weapon of preventive medicine, the panegyrics may be
premature.' Few detected diseases can be treated or cured in or ex utero
and second trimester abortion is generally the single "cure" for defects
which are diagnosed." Since most physicians agree that there is no point
in administering the test unless patients are willing to abort," it may be
preventive medicine only in the sense of the biblical mandaie - if the eye
is an occasion of sin, pluck it out.
Amniocentesis was developed initially to diagnose and manage cases
of RH incompatability. At the present time it can determine fetal sex and
detect a varied assortment of chromosomal conditions and metabolic
diseases. It is generally recommended by some physicians for pregnancies where there is advanced maternal age or a family history of Down's
Syndrome, although it is reported that the majority of infants with Down's
Syndrome are now born to women less than thirty-five years of age."
Amniocentesis is also recommended where there is a family history of
spina bifida or muscular dystrophy, mental retardation in close relatives,
Eastern European ancestry for Tay-Sachs disease and dispositive carrier
status for sickle cell trait."
The most recent use of large-scale amniocentesis has been in
connection with prenatal screening and the diagnosis of neural tube
defects which are among the most common major congenital defects in
the United States. Detection of neural tube defects results from a five part
testing procedure which culminates in amniocentesis."
The process of amniocentesis involves examination of amniotic fluid
to determine the extent of the presence of alpha-fetoprotein, a protein
which is produced by the child while developing in utero. It appears in the
amniotic fluid at increasing levels during the first fourteen weeks of
pregnancy and after that time the level declines. Alpha-fetoprotein (AFP)
is also found in the mother's blood. Research has shown that by
'Culletin, Amniocentesis: HEW Backs Test for Prenatal Diagnosis of Disease, 190 SCIENCE 537.
540 (1975).
'o Milunsky, Pre-Natal Diagnosis of Genetic Disorders. 70 AM. J. MED. 7, 8 (1981); Luy, Genetic
Detection-The Newest Use of Amniocentesis, MOD. MED., Sept. 2, 1974. at 31, 36.
"See, e.g., Chapman, What Are Your Odds in the Prenatal Gamble? LEGAL AsPEcTs OF MEDICAL
PRACTICE, March, 1979, at 30. 33.
"Id., at 32.
"Holmes, Genetic Counseling for the Older Woman, 298 NEw ENG. J. MED. 1419-21 (1978).
"Antenatal Diagnosis: What Is Standard? 241 J.A.M.A. 1666, 1667 (1979).
I Maternal Serum Alpha-Fetoprotein: Issues in the Prenatal Screening and Diagnosis of Neural
Tube Defects, in PROCEEDINGS OF A CONFERENCE HELD BY THE NATIONAL CENTER FOR HEALTH
CARE TECHNOLOGY AND THE FOOD AND DRUG ADMINISTRATION, in Washington, D.C. (July

28-30, 1980). at pp. 1-20.
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measuring the levels of AFP in amniotic fluid it is possible to detect
neural tube defects." However, not all neural tube defects can be
diagnosed. High AFP levels may occur on a statistical basis or may
represent an anomaly other than neural tube defects."
The Food and Drug Administration has received several applications
for premarket approval of AFP test kits which are defined by the FDA as
"reagents and other materials for use in the diagnosis of neural tube
defects in fetuses by analysis of the amount of alpha-fetoprotein (AFP) in
the blood serum (or plasma) and amniotic fluid of pregnant women."'
Since these kits were not marketed commercially in the United States
before the Medical Device Amendments Act of 1976 was enacted, they
are included as a class III device under the Food, Drug and Cosmetic
Act" and therefore require FDA approval before being marketed. The
FDA, however, has refrained from granting premarket approval while it
determines what restrictions are necessary to assure safety and effectiveness of the kits.
The FDA has stated that it is in a dilemma in deciding the conditions
under which the test kits can be used safely and effectively." While some
have argued that the kits should be given the widest possible distribution,
consumer organizations, health professionals and specialists in AFP
testing have expressed serious reservations. Specifically, these groups
have informed the FDA that unrestricted use of the AFP kits could
increase the number of abortions of normal infants, minimize identification of affected infants, and heighten anxiety over the outcome of
pregnancy.
Cognizant of these problems, the FDA has proposed regulations
which focus upon controlled conditions for use. An AFP program would
be required to have a coordinator who assures the FDA in writing that the
program is in compliance with the FDA regulations. Within its organizational structure, a program would be required to provide access to
services such as amniocentesis, ultrasonography and other laboratory
services necessary for proper diagnostic follow-up.
Milunsky. Prenatal Detection of Neural Tube Defects. 244 J.A.M.A. 2731 (1980).
Golbus. Loughman. Epstein. Halsbasch. Stephens & Hall. Prenatal Genetic Diagnosis in 3000
Amniocenteses. 300 Nuw ENG. J. MED. 157 (1979).
"45 Fed. Reg. 74.171 (1980).
21 U.S.C. § 360c(f)(1).
* 45 Fed. Reg. 74.159 (1980).
Id.
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Specifically, a competent diagnostic ultrasound service would be
required to be available that is capable of detecting multiple fetuses,
anencephaly, fetal death and gestational age. Amniocentesis would be
available for all women in the program who requested it. The FDA has
opined that its approval of the AFP test kit would significantly increase
the number of amniocentesis procedures performed each year and has
questioned whether the supply of such services would be adequate.
The program coordinator would be required to provide qualified
personnel for counseling which would be based on a policy of voluntary
participation, particularly with respect to available options when defects
are detected. Laboratories would be required to be part of a program
enrolled with the FDA to purchase AFP kits and could accept samples
only from physicians who were similarly part of such a program."
Regardless of whether or not amniocentesis is performed in the
context of an FDA enrolled program, there are recognized procedures
designed to insure the medical and genetic integrity of the process.
Typically, amniocentesis will be preceded by genetic counseling to insure
that family pedigree can be recorded, relevant genetic facts can be
evaluated and the psychological ramifications of pre-natal diagnosis may
be explained.' It is recommended that amniocentesis also be preceded by
an ultrasound investigation to determine the location of the placenta prior
to uterine puncture and to evaluate the gestational age of the child." The
actual procedure is usually performed between the sixteenth and twentieth
week of pregnancy by perforating the maternal abdominal wall and
uterus. Amniotic fluid is then withdrawn." In cases of multiple gestation
it is possible to obtain amniotic fluid from both sacs. 27 The fluid is
examined by karyotyping and biochemical analysis and this requires
highly trained technicians and competent laboratories. Amniocentesis
may also be performed transvaginally from the twelfth to the fifteenth
week of pregnancy but this is considered risky."
1 45
23

Fed. Reg. 74,161, 74,162 (1980).

Id. at 74,162.

Golbus, supra note 17, at 157.
Milunsky, supra note 10, at 7.

A

2
2

Fuchs, Amniocentesis and Abortion: Methods and Risks, in
DIAGNOSIs (D. Bergsma, ed., 1971).

n Golbus, supra note 17, at 160.
"Fuchs, supra note 26, at 19.

SYMPOSIUM ON INTRAUTERINE
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Amniocentesis is by no means a risk-free procedure." A study
published in Britain in 1978 showed that damage to normal pregnancies
from amniocentesis included increased change of respiratory distress
syndrome, abruptio placenta and fetal morbidity." Apart from the
physical problems, emotional problems also have been reported.'
Finally, one of the biggest technical problems is the receiving and
communicating of accurate test results." Current laboratory services are
overburdened and it has been predicted that a major increase in demand
may result in an unacceptable error rate. Also, because this is a potential
$100 million industry, there is the additional concern that profit may take
precedence over quality control."
In a study conducted by the National Institute of Child Health and
Human Development, there were six inaccurate diagnoses out of 1040
tests performed." Two infants were born with Down's Syndrome which
amniocentesis failed to detect. There were three cases of mistaken sexual
identification and one mistaken diagnosis of galactosemia in a child who
proved to be healthy at birth. A study published in 1979, indicated that out
of 3000 tests performed, fourteen diagnostic errors were found, six of
which affected the outcome of the pregnancy." In that same study, of
sixty-four abortions performed for chromosomal abnormalities, it was
possible to verify only forty-two of them cytogenetically.
* The feto-maternal risks involved are: spontaneous abortion (In Golbus' study, supra note 17,
published in 1979, which involved 3000 amniocenteses, there were 42 spontaneous abortions
before 28 weeks. This represents a rate of 1.5% which is similar to the rate found in studies
conducted in Europe and Canada.); secondary sterility, Fuchs, supra note 26, at 19; fetal death due
to needle lesion: amniotic fluid infection, Fuchs, supra note 26. at 18, 19 (see also Alexander,
Workgroup Paper: Risks of Amniocentesis. in PROCEEDINGS. supra note 15, at 20); placenta
rupture. Friedman. Legal Implications of Amniocentesis. 123 U. PA. L. REV. 92, 106 n.87 (1974);
inflamation of the amniotic sac, Gerbie, Nadler & Gerbie, Amniocentesis in Genetic Counseling,
109 Am. J. OBsT. & GYN. 765. 767 (1971); fetal scarring and eye-damage. Friedman, supra, at
106 nn.89. 91: maternal peritonitis due to perforation of the intestines and feto-maternal
hemorrhage due to perforation of the placenta, Fuchs, supra note 26, at 18, 19.
* An Assessment of the Hazards of Amniocentesis: Report of the M.R.C. Working Party on
Amniocentesis. 1978 BRIT. J. OBsT. & GYN. 85, Supp. 2.
Golbus, supra note 4: Amniocentesis-Abortion Woes, MED. WORLD NEws, July 12. 1976. at 72;
Brody. Genetic Defects Sought in Fetus: Goal Is To Find Them When Abortion Is Still Possible,
N.Y. Times. May 12. 1976: Blumberg. Golbus & Hanson. The Psychological Sequalae of
Abortion Performed for a Genetic Indication. 122 AM. J. OBsT. & GYN. 799 (1975).
Golbus. supra note 17.
Editorial. supra note 8.
Midtrimester Amniocentesis for Prenatal Diagnosis. 236 J.A.M.A. 1471 (1976). See generally
Risks of Amniocentesis, LANCET. Sept. 15. 1979. at 578. Milunsky. Amniocentesis. in GENETIC
DISORDERS AND THE FETus 27-42 (A. Milunsky. ed., 1979).
" Golbus. supra note 17.

HUMAN QUALITY CONTROL

353

U. ABORTION, EUTHANASIA AND AMNIOCENTESIS
Abortion, more often than not, is the preferred and recommended
course of action where amniocentesis reveals abnormalities." A National
Institute of Health Consensus Development Conference estimated in 1979
that of fetuses found to be defective through pre-natal diagnosis, over 95%
were aborted." The time lapse between amniocentesis and abortion has
been reported to vary between 32.2 days where a karyotype investigation
was performed to 45.3 days when there was a biochemical investigation."
Abortion is generally chosen since few of the detected diseases can
be cured or even treated in utero at the present time." One physician has
predicted that if intrauterine treatment of genetically diseased infants does
become possible, most families will still choose abortion since it has
already been reported that some parents have chosen to abort when the
simple remedy of a corrective diet would have permitted a child to lead a
normal life.' The state of the law in relation to abortion may also have
some impact in this regard.
Elective abortion became a legal act in 1973 .' Although there are
certain limitations on when it can be performed, it is always permissible
when a woman's life or health is at stake.4 ' The Supreme Court never
clearly defined the word "health" but implied that it should be employed
in its broadest context.' The Court listed some of the detriments which
affect health such as abandoning educational plans, sustaining a loss of
income and foregoing the satisfaction of a career." Although improbable,
it is possible that these psychological and socio-economic considerations
affecting health will not mature until the 280th day of gestation and thus,
even at full term, under certain circumstances, a woman may choose
abortion over regular delivery.'
" Lieberman, Psychological Aspects of Selective Abortion, in SYMPOSIUM, supra note 26, at 20;
Finley, Varner. Vinson & Finley, Participants' Reaction to Amniocentesii and Prenatal Genetic
Studies, 238 J.A.M.A. 2377, 2379 (1977).
" DHEW, Public Health Service, NIH No. 79-2973, ANTENATAL DIAGNOSIs: REPORT OF A
CONSENSUS DEVELOPMENT CONFERENCE 1-79.
* Golbus, supra note 17, at 160.
3'
Luy, supra note 10, at 36. However, successful prenatal treatment of genetic disorders of vitamin
B12 metabolism has been reported. Jones. Prenatal Diagnosis Of Birth Defects, I PERINATAL
CARE 10. 17 (1977).
* McBride, Prenatal Diagnosis: Problems and Outlook, 222 J.A.M.A. 132, 135 (1972).
" Roe v. Wade, 410 U.S. 113 (1973).
'* Id. at 164.
) Id. at 207, 208.
*Id. at 215.
"It becomes critical then to appreciate the definition of abortion, a term which has been variously
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Prior to 1973, abortion was generally available for eugenic reasons
under the nomenclature of a selective or therapeutic abortion.' The word
eugenic was first used by Sir Francis Galton in 1883 as the name of a
science directed toward improving hereditary qualities in a particular race
by eliminating the unfit.' Eugenic abortions refer to those performed to
prevent the birth of a defective or malformed child."
As the set of eugenic reasons constantly expands, we are confronted
with a situation perhaps not imagined by the proponents of eugenic
abortion prior to its legalization-sexual preference abortions. Chicago
Tribune columnist Joan Beck makes this observation:
Abortion is increasingly being used to end the life of healthy unborn infants just
because they are not of the sex their parents prefer. And almost all of the unborn
babies aborted for no other reason except that they are of an unwanted sex are
female.""

The reasons underlying male sexual preference are unclear. One
couple of Asian ancestry who had three daughters sought amniocentesis
to ascertain whether the wife was carrying a boy since their culture placed
a high value on male heirs. They stated that if the physician refused to
perform the amniocentesis for that purpose, they would abort in any
event." Where physicians have been reluctant to perform amniocentesis
for sexual preference reasons, some women have concocted various
defined. As will become evident, it is inappropriate to label the termination of pregnancy after
viability an abortion. See, e.g., D. CAVENAUGH & M. TALISMAN, PREMATURITY AND THE
OBSTETRICIAN 4 (1969), where abortion is defined as "the expulsion or extraction of all
(complete) or any part (incomplete) of the product of conception that weighs less than 500 g. alive
or dead." See also J. GREENHILL, OBsTETRIcs 265 (13th ed. 1965) ("interruption of pregnancy
before the fetus is viable"); A Statement on Abortion by One Hundred Professors of Obstetrics,
112 AM. J. OosT. & GYN. 922 (1972) states:
It should be emphasized that abortion is medically defined as the termination of pregnancy
before the end of the twentieth week. Regardless of the wording of a particular state law,
therefore, abortions should not be performed for purely social reasons beyond this gestational
age. Every effort should be made, of course, to perform abortions before the end of the first
trimester.
Id. at 923.
* Nadler & Gerbie. Role of Amniocentesis in the Intrauterine Detection of Genetic Disorders, 282
NEw ENG. J. MED. 596. 599 (1970). Kindregan. Abortion, the Law and Defective Children: A
Legal Medical Study. 3 SLFFOLK U. LAw REv. 226. 243-247 (1969).
' Kindregan. supra note 46. at 226.
4* Id. at 246.
Beck, Abortion-Signs of Trouble Ahead. AMERICAN MEDICAL NEWS, Nov. 22. 1976; see also
Fletcher. Ethics and Amniocentesis for Fetal Sex Identification, 301 NEw ENo. J. MED. 550. 552
(1979).
Young, Now You Can Pick Your Child's Sex-If... . National Observer. Oct. 30. 1976. at 3.
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stories." In 1972 it was reported that a 38-year-old woman, desirous of a
second son, sought amniocentesis under the guise of concern about
Down's syndrome. After being informed that she was carrying a female,
she obtained an abortion." This prompted an editorial in the Journal of the
American Medical Association:
Abortion is often called "therapeutic." What name should be given to the
abortion demanded solely because the sex of the fetus displeases the parents to
be?"

There seems to be no clear agreement among physicians on this
issue. One physician has recommended that labs performing amniocentesis withhold the sex of the fetus unless it is crucial to the management of
the case.' One of the initial developers and most ardent advocates of
amniocentesis favors abortion where the test results show an undesired
sex and would also favor abortion if the test revealed that the child would
become afflicted with cancer in mid-life." It has also been suggested that
sexual preference abortions are no more objectionable than those performed to facilitate a woman's travel plans.' In any event, description of
abortion based upon sexual preference as "eugenic" or "therapeutic" is
largely academic in view of the legality of abortion under the current state
of the law."
It is interesting to note that the rationale which supports eugenic
abortion is equally supportive of eugenic euthanasia, when defective
infants "slip through the screen and are born."" And, with viability now
occurring in the second trimester and abortions following amniocentesis
being performed in the second or third trimester, many defective infants
will indeed be born." Unlike abortion however, euthanasia is broadly held
to be illegal. The act of birth confers legal personhood, a status which is
protected by our judicial system. But present law is based upon the
traditional western ethic which attaches value to all human life. Advocates
sKnox, Doctor's Dilemma: Abortion If Fetus is Wrong Sex, Boston Globe, Aug. II, 1976, at 1. col.
I & 2.
3 An Abuse of Prenatal Diagnosis, 221 J.A.M.A. 408 (1972).
"Abortion: A Special Demand. 221 J.A.M.A. 400 (1972).
' An Abuse, supra note 52.
"HOWARD & RIFKIN, supra

note 3. at 141.

"Fletcher, supra note 49, at 552.
"See text accompanying note 45, supra.
"Fletcher, Abortion, Euthanasia and Care of Defective Newborns. 292 Naw
(1975).
"Henig, The Child Savers, N.Y. Times Mag., March 22, 1981, at 34.

ENG. I.

MED. 75
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of a quality of life ethic do not necessarily recognize a continued right to
life after birth. Nobel laureate, Sir Francis Crick, has stated that "...no
newborn infant should be declared human until it has passed certain tests
regarding its genetic endowment and ... if it fails these tests, it forfeits
the right to life."' An equally preposterous suggestion is that a child
achieve a minimum I.Q. test score of 20-40 before being considered
human."
III. AMNIOCENTESIS AND WRONGFUL LIFE/BIRTH
LITIGATION
The existence of amniocentesis as a pre-natal detection technique has
generated a unique set of malpractice litigation, specifically labeled
wrongful life actions.' These actions are brought by parents on behalf of
a child seeking damages resulting from the fact of the child's birth. The
theoretical justification for the action is that but for the defendant/
physician's negligence, the child would not have been born."
Wrongful life actions are distinguishable from wrongful birth actions
which are brought by the parents of the affected child and typically allege
that had they been informed of the existence of amniocentesis, it would
have been performed and the defective child would have been aborted. In
wrongful birth actions the parents usually seek damages for pain and
suffering, loss of consortium, emotional distress, loss of wages, medical
expenses and the costs of raising the child." In 1967, damages were first
awarded to parents in a wrongful birth case and the trend today is toward
recovery for the parents."
Courts have uniformly rejected wrongful life claims on two grounds.
Frankel, The Specter of Eugenics. Commentary. March. 1974.
WHO SHALL LivE? 77 (1976).
* See generally Father and Mother Know Best: Defining the Liability of Physicians for Inadequate
Genetic Counseling. 87 YALE L.J. 1488 (1978): Capron. Tort Liability in Genetic Counseling. 79
CoLum. L. REv. 618 (1979); Trotzig. The Defective Child and the Actions for Wrongful Life and
Wrongful Birth, 14 FAM. L.Q. 15 (1980).
"The "amniocentesis" cases are: Fiegelson v. Ryan. N.Y.L.J. Feb. 24. 1981, at 5; Berman v. Allen.
80 N.J. 421. 404 A.2d 8 (1979): Becker v. Schwartz. 60 App. Div. 2d 587. 400 N.Y.S.2d 119
(1977). modified. 46 N.Y.2d 401. 413 N.Y.S.2d 895 (1978). Gildiner v. Thomas Jefferson Univ.
Hosp.. 451 F. Supp. 692 (E.D. Pa. 1978f; Johnson v. Yeshiva Univ.. 53 App. Div. 2d 523, 384
N.Y.S.2d 4S5 (1976). affd. 42 N.Y.2d 818. 396 N.Y.S.2d 647 (1977): Karlsons v. Guerinot. 57
App. Div. 2d 73. 394 N.Y.S.2d 933 (1977): Greenberg v. Kliot. 47 App. Div. 2d 765. 367 N.Y.S.
2d 966. leave to appeal denied. 37 N.Y.2d 707. 375 N.Y.S.2d 1026 (1975).
* Curlender v. Bio-Science Laboratories. 106 Cal. App. 3d 811. 165 Cal. Rptr. 477 (1980). For an
excellent collection of the recent wrongful birth cases. see Trotzig. supra note 62. n.6.
Custodio v. Bauer. 251 Cal. App. 2d 303. 59 Cal. Rptr. 463 (1967).
SWEBER.
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First, it is difficult to assess damages. Tort damages are compensatory in
nature and designed to put the party in the position in which he or she
would have been but for the negligence of the defendant. In a wrongful
life action the court would be required to weigh the value of an impaired
life against the non-existence of that life."
The second justification for judicial rejection of wrongful life claims
is based on a public policy which favors the continuing reaffirmation of
the value of life ethic. The most recent case involving a wrongful life
claim noted that "... in some fashion, a deeply held belief in the sanctity
of life has compelled some courts to deny recovery....""
The landmark wrongful life case which has served as precedent in
denying relief in the amniocentesis cases is Gleitman v. Cosgrove." Mrs.
Gleitman contracted rubella during the first trimester of her pregnancy
and her child was born with serious impairments. The plaintiffs alleged
that the defendant knew of Mrs. Gleitman's condition but failed to inform
her of any potentially harmful consequences to the child and therefore
sought damages for wrongful life and wrongful birth. The New Jersey
Supreme Court denied recovery to either the child or the parents stating
that "life with defects" was better than "no life at all" and that it would be
impossible to assess damages. Even if Mrs. Gleitman could have obtained
a legal abortion, the court noted that public policy disfavored allowing
recovery for "the denial of the opportunity to take an embryonic life."69
Gleitman has been followed in virtually all wrongful life cases,
including the amniocentesis cases, to deny damages to the child.
However, since the legalization of abortion in 1973, there has been a
retreat from that holding with respect to the parents' right to recover. In
Berman v. Allen," the Supreme Court of New Jersey recognized a cause
of action by parents against a physician for medical malpractice in failing
'See, e.g., Berman v. Allen. 80 N.J. 421. 425. 404 A.2d 8. 12 (1979). See also Comment.
Wrongful Life and a Fundamental Right to be Born Healthy: Park r: Chessin. Becker r: Schwartz,
27 BUFFALo L. REv. 537 (1978); Kashi. The Case of the Unwvanted Blessing: Wrongfd Life. 31 U.
MIAMI L. REv. 1409 (1977).
" Curlender v. Bio-Science Laboratories 165 Cal. Rptr. 477. 486 (1980).
"49 N.J. 22. 227 A.2d 689 (1967). The first wrongful life claim arose in Zepeda v. Zepeda. 41 Ill.
App. 2d 240. 190 N.E.2d 849 (1963). cert. denied. 379 U.S. 945 (1964). A healthy child
conceived out of wedlock sued his father, claiming injury due to his illegitimate birth status. While
the court recognized that a tortious act had been committed, it denied recovery on public policy
grounds stating that such a decision should be made by the legislature. See also Williams v. State,
18 N.Y.2d 481. 276 N.Y.S.2d 885. (1966).
"49 N.J. at 30, 227 A.2d at 693.
To 80 N.J. 421, 404 A.2d 8 (1979).
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to advise of the existence of amniocentesis after plaintiffs' child was born
with Down's Syndrome. The parents asserted that had they been advised
of amniocentesis, it would have been performed and the defective child
would have been aborted.
The infant's claim for wrongful life was rejected, however, based on
a reaffirmation of the value of life ethic articulated in Gleitman. The court
went to great lengths to reaffirm "the sanctity of life," quoting from the
Declaration of Independence and the United States Consiitution that "life
is one of three fundamental rights of which no man can be deprived
without due process."
The retreat from Gleitman was inextricably linked with the Supreme
Court's decision in Roe v. Wade which legalized abortion. The Berman
court stated that "public policy now supports, rather than militates
against, the proposition that [a woman] not be impermissibly denied a
meaningful opportunity to make [the] decision to abort at least during the
first trimester of pregnancy."" Thus, the essence of the injury in Berman
was that the parents were deprived of the right to exercise a decision
whether or not to abort.
While Berman continued the Gleitman rule disallowing economic
damages, it recognized that the defendant physicians had breached a duty
to the parents by failing to inform them of the availability of amniocentesis. This deprived the parents of the exercise of an option with respect to
acceptance or rejection of parenthood. Thus, the parents were allowed to
recover the "monetary equivalent of their distress" without making any
allowances for "the love and joy they will experience as parents.""
Damages for pecuniary loss were allowed in Becker v. Schwartz," a
wrongful life and wrongful birth action involving the failure of the
physicians to inform the parents of the existence of amniocentesis
resulting in the subsequent birth of a mongoloid child. The court held that
the parents could recover for their pecuniary loss but not for emotional
distress. In denying the child's claim the court reaffirmed the value of life
ethic and questioned whether wrongful life claims should ever be
recognized given the impossibility of knowing the true desires of the
child."
"

80 N.J. at 431-32. 404 A.2d at 13-15.

'2

Id.
60 App. Div. 2d 587. 400 N.Y.S.2d 119 (1977). modified. 46 N.Y.2d 401. 413 N.Y.S.2d 895
(1978).
This child was subsequently put up for adoption. Baby in Malpractice Suit Was Put Up for
Adoption. N.Y. Times. Feb. 17. 1979. at 23. col. 1. at 24. col. 1.
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In Johnson v. Yeshiva University," also a wrongful life and wrongful
birth action, no liability was imposed upon a physician for failure to
perform amniocentesis despite subsequent birth of a defective child. The
court upheld the physician's conduct as a "permissible exercise of
medical judgment and not a departure from then accepted medical
practice." In this case the plaintiff failed to establish that on the basis of
her medical history and the state of medical knowledge about amniocentesis in 1969, the defendant physician departed from accepted medical
practice.
In Gildiner v. Thomas Jefferson University Hospital,6 the court
recognized the existence of a cause of action for the negligent performance and interpretation of amniocentesis. After Linda Gildiner discovered
that she was pregnant, plaintiffs underwent a Tay-Sachs test which
determined that they were both carriers of Tay-Sachs disease. Amniocentesis was performed and plaintiffs were informed that the results eliminated any possibility that their child would be afflicted with Tay-Sachs.
Upon the birth of their child afflicted with Tay-Sachs, the parents
instituted a wrongful life and birth action.
Based upon the Gleitman rationale, the court rejected the child's
wrongful life action. But, the court recognized a cause of action on behalf
of the parents based upon general negligence principles. It noted that a
failure in the performance or interpretation of amniocentesis could result
in a healthy fetus being aborted or in the unwanted birth of a child with
Tay-Sachs disease and that both of these occurrences violated the public
policy of the state. Gildiner is internally inconsistent. By accepting
Gleitman the court accepts the proposition that life is more precious than
non-life. Therefore, the birth of a child whether unwanted by parents or
afflicted with Tay-Sachs disease cannot be violative of a state's public
policy.
The most recent case involving amniocentesis was dismissed on
procedural grounds. In Feigelson v. Ryan," damages were sought against
" 53 App. Div. 2d 523, 384 N.Y.S.2d 455 (1976). afid, 42 N.Y.2d 818, 364 N.E.2d 1340. 396
N.Y.S.2d 647 (1977). But see Karlsons v. Guerinot. 57 App. Div. 2d 73. 394 N.Y.S.2d 933
(1977), wherein the plaintiff, a 37-year-old woman brought an action after the birth of her
mongoloid child. She alleged that had she been informed of the existence of amniocentesis. she
would have undergone the process and aborted the defective child. Recovery was allowed the
mother on the theory that the defendants had a duty to provide proper prenatal care. The breach of
duty consisted of a failure to test for the existence of the deformity in light of the mother's previous
history which included a thyroid condition and the birth previously of a deformed child.
"451 F. Supp. 692 (E.D. Pa. 1978).
nN.Y.L.J. Feb. 24, 1981. at 5.
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physicians for their failure to perform amniocentesis. An artificial
insemination was performed upon plaintiff which resulted in pregnancy.
After the child was born on February 19, 1976, he underwent chromosomal analysis and it was discovered that he suffered from a chromosomal
disorder causing mental retardation and physical disability. Plaintiffs were
informed of this problem in May, 1977, and brought an action contending
that they were improperly advised regarding the risks of pregnancy for
women over the age of thirty-five. Had they been properly informed, it
was alleged, the mother would have undergone amniocentesis and upon
discovery of the genetic defect, would have aborted the child. However,
New York's three year statute of limitations in malpractice cases had
lapsed and the case was dismissed.
One of the issues raised by the amniocentesis cases is that of how a
court would react if faced with an action by parents who were unhappy
about the sex of their child. Considering the growing use of amniocentesis
to determine fetal sex and the Berman court's rationale in support of a
parental right of action for being deprived of the ability to make an
abortion decision, this potentiality is not so remote. It may well be that
these cases would be decided in the same manner as the cases dealing
with unwanted but otherwise healthy children. It is generally held that
plaintiffs who have attempted to prevent the birth of a child may collect
for medical expenses, loss of income, and pain and suffering from the
defendant whose negligence caused the child's conception."

IV. THE DILEMMA
The increased availability, advocacy and use of amniocentesis as a
panacea against the birth of infants possessed of defects or as a guarantee
of beautiful children or children of a desired sex, presents serious legalethical-moral considerations. While the potential for a perfect human
being seems to become real, the trade-off is diminished protection for
human beings qua human beings. Between these competing values lies a
host of uncomfortable issues.
There is what the British medical journal LANCET refers to as "the
79
ethical problems of over-kill of healthy fetuses."
n See Comment, Liability for Failure of Birth Control Methods. 76 CoWM. L. REV. 1187 (1976).
The Risk of Amniocentesis. LANCET. Dec. 16, 1978. at 1287.
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The dilemma lies in deciding what value should be placed on the gains of
terminating affected fetuses and the losses of killing normal fetuses. These
cannot simply be weighed against each other in numerical terms. The value of
terminating affected fetuses must depend on the likely degree of handicap and
its effect on parents, their families and society; some fetuses will be so severely
affected that they will be stillborn or die soon after birth, in which case
amniocentesis and termination cannot be said to have averted handicap. At the
other end of the scale, some will be only mildly affected and have a prospect of
almost normal lives. Between these two extremes lies a full range of physical
and mental disabilities."

Are we ready to accept the consequences of over-kill?
Additionally, when the possibility of error is considered, the potential for litigation is endless. In the National Institute of Child Health and
Human Development test which was sponsored by the government, and
which, one assumes, would have been conducted under ideal conditions,
there were errors. Who should bear the risk of loss in these cases? The
physician, genetic counselor, laboratory, parents? How should damages
be assessed when the aborted child is found to be without defect or of the
desired sex?
Finally, the question remains as to whether a law which permits
parents to eliminate a child of undesired sex before birth would extend
after birth where diagnosis was inaccurate? The majority of the population
would probably frown upon the exercise of the latter course of action as
homicide. Psychologically, in utero death by abortion is preferred to ex
utero death, since, as noted by the California Medical Journal in 1970, a
quality of life mentality has succeeded in separating the idea of abortion
from the idea of killing." This observation is reinforced by a comment
from the mother of a child with Tay-Sachs disease who has stated that
knowing that a child affected with Tay-Sachs can be "detected and
aborted" meant that she could become pregnant again without fear of
"watching" another of her children die."
The rights associated with parenthood seem somewhat confused
among the rights associated with marriage and childrearing. There is a
right to conceive" and not to conceive;" a right to know what has been
0Id. at 1288.
"A New Ethic for Medicine and Society. 113 CAL. MED.. 67, 68 (1970).
n Antenatal Diagnosis, supra note 14, at 1669.
"Skinner v. Williamson, 316 U.S. 438 (1942) (right to procreate).
* Eisenstadt v. Baird, 408 U.S. 438 (1972) (right of unmarried persons to use contraceptives):
Griswold v. Connecticut, 381 U.S. 479 (1965) (right of married persons to use contraceptives).

362

NOLAN-HALEY

conceived" and to eliminate the same." The logical outcome of this
quality of life ethic is that these rights may become obligations, social or
otherwise. Ethicist John Fletcher has stated:
With the availability of the technology and know-how permitting prevention of
many genetically based congenital abnormalities, there may be developing as a
corollary a social attitude which demands such use. In general, if a congenital
abnormality can be avoided, then it should be, and those individuals who do not
partake of these advances will be socially ostracized."

'

When will parents be forced to forfeit offspring who fail the quality
control specifications of judges? The idea is not entirely unreasonable in a
country where, under compulsory sterilization statutes, thousands of
Americans were sterilized involuntarily in a campaign to eliminate
biological inferiors from the American populace."
While one of the leading experts in amniocentesis, Dr. Henry L.
Nadler, believes that performing amniocentesis in every pregnancy
"would be like a hunting expedition," 89 it could become compulsory in
the name of public welfare as did sterilization." These observations
become less speculative as the quality of life ethic fully displaces the
traditional ethic and the obligation to beget only quality "products of
conception" is enforced. Already, it has been suggested that there be
compulsory controls when there is a failure to adhere to "humane
minimal standards of reproduction." 9
Coercion may be subtle and as one physician has noted, ... it is
sometimes difficult to distinguish coercion from choice." 92 If amniocentesis becomes publicly funded and large-scale advertising is undertaken,
there is the problem of guilt for women who decline to have the test
performed. 93 It is possible that amniocentesis could become publicly
"Becker v. Schwartz. 60 App.Div. 2d 587. 400 N.Y.S.2d 119 (1977), modified. 46 N.Y.2d 401, 413
N.Y.S.2d 895 (1978): Park v. Chessin. 400 N.Y.S.2d 110 (1977) (physician may be held liable in
negligence for failing to inform patients of the availability of amniocentesis in certain circumstances and of the risk of bearing abnormal children).
"Roe v. Wade, 410 U.S. 113 (1973).
h7 Sorenson. Some Social and Psychologic Issues in Genetic Screening, quoting John Fletcher. in
SYMposiuM. supra note 26. at 177.
"HOWARD & RwlKiN. supra note 3. at 57. See also Vacari, Legal Aspects of Compulsory
Sterilization in America. 3 INT'L REv. NAT. FAM. PLAN. 1 (1979).
"

McBride, supra note 40. at 132.
' See Friedman, supra note 29. at 122-142.

Laws Forbidding Some Persons From Reproducing Held Justified. Oas. & GYN. NEws, Aug. 1,
1979.
* Editorial. supra note 8.
" Id.
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funded to the extent that abortion is so funded and to the extent that AFP
screening programs become mandatory. The latter possibility is extremely
remote, however, since most commentators oppose any form of mandatory screening programs.'

CONCLUSION
Given the choice, few if any women would choose to conceive a
defective child just as few would choose to marry a person with a
progressively debilitating disease. But, after conception occurs, removing
defects from the womb should not be approached with the mechanical
nonchalance of removing a defective refrigerator. As noted by the New
York Court of Appeals, that which exists in the womb is human and it is
unquestionably alive.9 5
Medicine must encourage research to treat and cure in and ex utero
or there are no real choices. "Abortion is never therapeutic for the
fetus... .""Law must safeguard zealously the rights of those deemed
"defective," the most vulnerable members of society. In short, members
of the legal-medical community must insure that emphasis be placed upon
eliminating the "defect" not the "defective." Otherwise, the apotheosis
of human quality control will lead us out of control.
* See, e.g., supra note 15, at 37, 69.
"Byrn v. N.Y.C. Health & Hosp. Corp., 31 N.Y.2d 194, 199. 335 N.Y.S. 2d 390, 392 (1972),
appeal dismissed, 410 U.S. 949 (1973). In Byrn. the New York Court of Appeals upheld a law
permitting abortion but stated:
It is not effectively contradicted, if it is contradicted at all, that modem biological disciplines
accept that upon conception a fetus has an independent genetic "package" with potential to
become a full-fledged human being and that it has autonomy of development and character
although it is for the period of gestation dependent upon the mother ... and it is
unquestionably alive.
* Powledge & Fletcher, Guidelines for the Ethical. Social and Legal Issues in Prenatal Diagnosis.
300 NEw ENo. J. MED. 168, 171 (1979).

